Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, and the production of interferon γ in the absence of IL-12 during DC-T cell cognate interaction:: A new role for Fas ligand in inflammatory responses

被引:187
作者
Rescigno, M
Piguet, V
Valzasina, B
Lens, S
Zubler, R
French, L
Kindler, V
Tschopp, J
Ricciardi-Castagnoli, P [1 ]
机构
[1] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy
[2] Univ Hosp Geneva, Dept Dermatol, CH-1211 Geneva, Switzerland
[3] Unv Romand Dermatol & Venereol, Dept Hosp, CH-1211 Geneva, Switzerland
[4] Univ Lausanne, Inst Biochim, CH-1066 Epalinges, Switzerland
[5] Hosp Univ Vaudois & Genevois, Div Hematol, CH-1211 Geneva, Switzerland
关键词
dendritic cells; Fas; interleukin; 1; beta; FLIP; interferon gamma;
D O I
10.1084/jem.192.11.1661
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ligation of the Fas (CD95) receptor leads to an apoptotic death signal in T cells, B cells, and macrophages. However, human CD34(+)-derived dendritic cells (DCs) and mouse DCs, regardless of their maturation state, are not susceptible to Fas-induced cell death domain-like IL-1 beta -converting enzyme (FLICE)-inhibitory protein (FLIP) ligand. We demonstrate a new role of Fas in DC physiology. Engagement of Fas on immature DCs by Fas ligand (FasL) or by anti-Fas antibodies induces the phenotypical and functional maturation of primary DCs. Fas-activated DCs upregulate the expression of the major histocompatibility complex class II, B7, and DC-lysosome-associated membrane protein (DC-LAMP) molecules and secrete proinflammatory cytokines, in particular interleukin (IL)-1 beta and tumor necrosis factor alpha. Mature DCs, if exposed to FasL, produce even higher amounts of IL-1 beta. Importantly, it is possible to reduce the production of IL-1 beta and interferon (IFN)-gamma during DC-T cell interaction by blocking the coupling of Fas-FasL with a Fas competitor. Finally, during cognate DC-T cell recognition, IL-12 (p70) could not be detected at early or late time points, indicating that Fas-induced, IFN-gamma secretion is independent of IL-12.
引用
收藏
页码:1661 / 1668
页数:8
相关论文
共 29 条
[1]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[2]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[3]   Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14- and a CD34-CD14+ dendritic cell precursor [J].
Arrighi, JF ;
Hauser, C ;
Chapuis, B ;
Zubler, RH ;
Kindler, V .
BLOOD, 1999, 93 (07) :2244-2252
[4]  
Ashany D, 1999, J IMMUNOL, V163, P5303
[5]   TH1 CD4+ LYMPHOCYTES DELETE ACTIVATED MACROPHAGES THROUGH THE FAS/APO-1 ANTIGEN PATHWAY [J].
ASHANY, D ;
SONG, X ;
LACY, E ;
NIKOLICZUGIC, J ;
FRIEDMAN, SM ;
ELKON, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11225-11229
[6]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[7]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[8]   Dendritic cells as natural adjuvants [J].
Citterio, S ;
Rescigno, M ;
Foti, M ;
Granucci, F ;
Aggujaro, D ;
Gasperi, C ;
Matyszak, MK ;
Girolomoni, G ;
Ricciardi-Castagnoli, P .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (01) :142-147
[9]   Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity [J].
De Maria, R ;
Testi, R .
IMMUNOLOGY TODAY, 1998, 19 (03) :121-125
[10]  
De Smedt T, 1998, J IMMUNOL, V161, P4476